On February 13, Rosenblatt analyst Mike Genovese upgraded the stock to “Buy” from Neutral with a price target of $80, up from $66. The rating, issued after the company’s earnings report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results